73 results
Page 2 of 4
8-K
EX-99.3
l1yhmaze2txa ea1
13 Dec 21
Other Events
5:28pm
8-K
EX-99.1
04wcpvz
13 Dec 21
Other Events
5:28pm
8-K
EX-99.1
y4mnt2i3nz29um9
5 Aug 21
Harpoon Therapeutics Reports Second Quarter 2021 Financial Results and Provides Corporate Update
4:22pm
8-K
EX-99.1
43lk1cyl l1i
4 Jun 21
Harpoon Therapeutics Presents Updated Interim Clinical Data for the PSMA-targeting TriTAC® HPN424 at the 2021 ASCO Annual Meeting
4:40pm
8-K
EX-99.2
pgs h857o0
4 Jun 21
Harpoon Therapeutics Presents Updated Interim Clinical Data for the PSMA-targeting TriTAC® HPN424 at the 2021 ASCO Annual Meeting
4:40pm
8-K
EX-99.3
ox8dewm 56d7l
4 Jun 21
Harpoon Therapeutics Presents Updated Interim Clinical Data for the PSMA-targeting TriTAC® HPN424 at the 2021 ASCO Annual Meeting
4:40pm
8-K
EX-99.2
qm1q4ipjxr le
7 Jan 21
Harpoon Therapeutics Announces Pricing of Public Offering of Common Stock
4:20pm
8-K
EX-1.1
xi9s3vrc9e8c w1a
7 Jan 21
Harpoon Therapeutics Announces Pricing of Public Offering of Common Stock
4:20pm
424B5
ywyx 9c4g
7 Jan 21
Prospectus supplement for primary offering
4:16pm
424B5
05roxlmwz3y
6 Jan 21
Prospectus supplement for primary offering
4:43pm
8-K
EX-99.1
jj01w865nmt4 xn
11 Dec 20
Other Events
5:06pm
8-K
EX-99.1
wc7cvf
5 Aug 20
Harpoon Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update
4:12pm
8-K
EX-99.1
vw3rrt4c0s624mh5q
29 May 20
Harpoon Therapeutics Presents Interim Phase 1 Data from an Ongoing Dose
4:03pm